Kurma Partners
Amanda Gett-Chaperot is a seasoned investment professional with extensive experience in the healthcare sector, currently serving as a Partner at Kurma Partners since 2023 and previously as a Partner at Seventure Partners from 2019 to 2023. At Seventure Partners, Amanda focused on investments in biotech, digital health, and intersections with food and nutrition. With earlier roles as Principal at Seventure Partners and Investment Manager at Roche, Amanda contributed to corporate venture fund initiatives, specializing in life sciences, pharmaceuticals, and diagnostics. Amanda's background also includes significant business development experience, including the execution of strategic partnerships and collaborations in early-stage research. Amanda holds a Global Executive MBA from IE Business School and multiple degrees in immunology from the University of Sydney and institutions in Switzerland.
This person is not in the org chart
This person is not in any teams
Kurma Partners
Founded in July 2009, Kurma Partners is a key European player in the financing of Innovation in Healthcare and Biotechnology, from pre-seed to growth capital, Kurma Partners operates over the whole value chain and has the following activities: Fund management of Kurma Biofund I, (size of 51 million euros) Kurma Biofund I is an investment fund which is focused on life sciences and healthcare. It is dedicated to establishing a new economic model for the financing of innovation: a model based on strategic partnerships with the most highly reputable biotechnology and medical research centers in France and Europe. Kurma Biofund I is particularly interested in early stage projects, even those at the very leading edge of technology, aiming to transform them into viable entrepreneurial projects and bring them to fruition within three to five years.